50090-3483 : Trulicity 1.5 mg/.5ml Subcutaneous Injection, Solution


NDC50090-3483
Labeler: A-s Medication Solutions
Product Type: Human Prescription Drug
Drug Name:  Trulicity
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA125469
Rev. Date: 


NDC Package Codes:

  • 50090-3483-0: 4 SYRINGE IN 1 CARTON (50090‑3483‑0) > .5 ML IN 1 SYRINGE

Active Ingredients:

  • Dulaglutide

Dosage Strength:

  • 1.5 mg/.5mL

Pharmaceutical Classes:

  • GLP-1 Receptor Agonist [EPC]
  • Glucagon-Like Peptide 1 [CS]
  • Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

Related Products:

Based on records with the same trade name.
  • 50090-3484 Trulicity .75 mg/.5ml Subcutaneous Injection, Solution by A-s Medication Solutions
  • 0002-1433 Trulicity .75 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly and Company
  • 0002-1434 Trulicity 1.5 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly and Company
  • 54568-433 Trulicity .75 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly Italia Spa
  • 54568-434 Trulicity 1.5 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly Italia Spa

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50090-3483 QR Code

< Prev: 50090-3482Next: 50090-3484 >

Related Discussions:

Trulicity For Diabetes
Starting in mid-July will Trulicity (0.75mg) be available? It is marketed for use in treating type 2 diabetes. ## It is ... 1 reply




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 8 July 2018.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA